Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate Cancer
SCHER, Howard I, XIAOYU JIA, MELUCH, Anthony A, NORDQUIST, Luke T, VENNER, Peter M, HEIDENREICH, Axel, CHU, Luis, HELLER, Glenn, CHI, Kim, DE WIT, Ronald, BERRY, William R, ALBERS, Peter, HENICK, Brian, WATERHOUSE, David, RUETHER, Dean J, ROSEN, Peter J
Published in Journal of clinical oncology (01.06.2011)
Published in Journal of clinical oncology (01.06.2011)
Get full text
Journal Article
An event-related examination of neural activity during social interactions
Themanson, Jason R, Khatcherian, Stephanie M, Ball, Aaron B, Rosen, Peter J
Published in Social cognitive and affective neuroscience (01.08.2013)
Published in Social cognitive and affective neuroscience (01.08.2013)
Get full text
Journal Article
Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer
Borad, Mitesh J, Reddy, Shantan G, Bahary, Nathan, Uronis, Hope E, Sigal, Darren, Cohn, Allen L, Schelman, William R, Stephenson, Jr, Joe, Chiorean, E Gabriela, Rosen, Peter J, Ulrich, Brian, Dragovich, Tomislav, Del Prete, Salvatore A, Rarick, Mark, Eng, Clarence, Kroll, Stew, Ryan, David P
Published in Journal of clinical oncology (01.05.2015)
Published in Journal of clinical oncology (01.05.2015)
Get full text
Journal Article
A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea
Verstovsek, Srdan, Passamonti, Francesco, Rambaldi, Alessandro, Barosi, Giovanni, Rosen, Peter J., Rumi, Elisa, Gattoni, Elisabetta, Pieri, Lisa, Guglielmelli, Paola, Elena, Chiara, He, Shui, Contel, Nancy, Mookerjee, Bijoyesh, Sandor, Victor, Cazzola, Mario, Kantarjian, Hagop M., Barbui, Tiziano, Vannucchi, Alessandro M.
Published in Cancer (15.02.2014)
Published in Cancer (15.02.2014)
Get full text
Journal Article
A Phase I Single-Agent Study of Twice-Weekly Consecutive-Day Dosing of the Proteasome Inhibitor Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma or Lymphoma
ALSINA, Melissa, TRUDEL, Suzanne, FURMAN, Richard R, ROSEN, Peter J, O'CONNOR, Owen A, COMENZO, Raymond L, WONG, Alvin, KUNKEL, Lori A, MOLINEAUX, Christopher J, GOY, Andre
Published in Clinical cancer research (01.09.2012)
Published in Clinical cancer research (01.09.2012)
Get full text
Journal Article
The effects of social exclusion on the ERN and the cognitive control of action monitoring
Themanson, Jason R., Ball, Aaron B., Khatcherian, Stephanie M., Rosen, Peter J.
Published in Psychophysiology (01.03.2014)
Published in Psychophysiology (01.03.2014)
Get full text
Journal Article
A phase I/II study of carfilzomib 2–10-min infusion in patients with advanced solid tumors
Papadopoulos, Kyriakos P., Burris, Howard A., Gordon, Michael, Lee, Peter, Sausville, Edward A., Rosen, Peter J., Patnaik, Amita, Cutler, Richard E., Wang, Zhengping, Lee, Susan, Jones, Suzanne F., Infante, Jeffery R.
Published in Cancer chemotherapy and pharmacology (01.10.2013)
Published in Cancer chemotherapy and pharmacology (01.10.2013)
Get full text
Journal Article
Safety and efficacy of pomalidomide, dexamethasone and pegylated liposomal doxorubicin for patients with relapsed or refractory multiple myeloma
Cohen, Alexa, Spektor, Tanya M., Stampleman, Laura, Bessudo, Alberto, Rosen, Peter J., Klein, Leonard M., Woliver, Thomas, Flam, Marshall, Eshaghian, Shahrooz, Nassir, Youram, Maluso, Tina, Swift, Regina A., Vescio, Robert, Berenson, James R.
Published in British journal of haematology (01.01.2018)
Published in British journal of haematology (01.01.2018)
Get full text
Journal Article
A Phase Ib Study of AMG 102 in Combination with Bevacizumab or Motesanib in Patients with Advanced Solid Tumors
ROSEN, Peter J, SWEENEY, Christopher J, YEE, Lorrin K, PARK, Dorothy J, BEAUPRE, Darrin M, HONGJIE DENG, LEITCH, Ian M, SHUBHAKAR, Poornima, MIN ZHU, OLINER, Kelly S, ANDERSON, Abraham
Published in Clinical cancer research (01.05.2010)
Published in Clinical cancer research (01.05.2010)
Get full text
Journal Article
Alterations in error-related brain activity and post-error behavior over time
Themanson, Jason R., Rosen, Peter J., Pontifex, Matthew B., Hillman, Charles H., McAuley, Edward
Published in Brain and cognition (01.11.2012)
Published in Brain and cognition (01.11.2012)
Get full text
Journal Article
A Multicenter, Phase 2 Study of Vascular Endothelial Growth Factor Trap (Aflibercept) in Platinum- and Erlotinib-Resistant Adenocarcinoma of the Lung
Leighl, Natasha B., Raez, Luis E., Besse, Benjamin, Rosen, Peter J., Barlesi, Fabrice, Massarelli, E., Gabrail, Nashat, Hart, Lowell L., Albain, Kathy S., Berkowitz, Lloyd, Melnyk, Ostap, Shepherd, Frances A., Sternas, Lars, Ackerman, Judie, Shun, Zhenming, Miller, Vincent A., Herbst, Roy S.
Published in Journal of thoracic oncology (01.07.2010)
Published in Journal of thoracic oncology (01.07.2010)
Get full text
Journal Article
Triple-Drug Transcatheter Arterial Chemoembolization in Unresectable Hepatocellular Carcinoma: Assessment of Survival in 124 Consecutive Patients
Gomes, Antoinette S, Rosove, Michael H, Rosen, Peter J, Amado, Rafael G, Sayre, James W, Monteleone, Phillip A, Busuttil, Ronald W
Published in American journal of roentgenology (1976) (01.12.2009)
Published in American journal of roentgenology (1976) (01.12.2009)
Get full text
Journal Article
A phase II trial of irinotecan in hormone-refractory prostate cancer
REESE, D. M, TCHEKMEDYIAN, S, CHAPMAN, Y, PRAGER, D, ROSEN, P. J
Published in Investigational new drugs (1998)
Published in Investigational new drugs (1998)
Get full text
Journal Article
A Phase 1/2 Trial of Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Patients with Relapsed/Refractory Multiple Myeloma
Berenson, James R., Stampleman, Laura V., Bessudo, Alberto, Rosen, Peter J., Klein, Leonard M, Woliver, Thomas, Flam, Marshall S., Eshaghian, Shahrooz, Nassir, Youram, Swift, Regina A., Vescio, Robert
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
a Phase 1/2 Trial of Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Berenson, James, Stampleman, Laura, Bessudo, Alberto, Rosen, Peter J, Klein, Leonard M., Woliver, Thomas, Flam, Marshall S., Eshaghian, Shahrooz, Nassir, Youram, Regina, Swift A, James, Wang, Benjamin, Eades, Spektor, Tanya M., Vescio, Robert
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
A phase 1/2 study of pomalidomide (POM), dexamethasone (DEX), and pegylated liposomal doxorubicin (PLD) for patients with relapsed/refractory multiple myeloma (RRMM)
Berenson, James R., Klein, Leonard M., Rosen, Peter J., Woliver, Thomas B. S., Eshaghian, Shahrooz, Nassir, Youram, Swift, Regina A., Vescio, Robert A.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
2-O, 3-O Desulfated Heparin (ODSH) May Mitigate Chemotherapy-Induced Thrombocytopenia and Neutropenia in Patients Treated with Combination Gemcitabine (G)/Nab-Paclitaxel (A), a Myelosuppressive Chemotherapy Regimen
Sigal, Darren, Marcus, Stephen, Cohen, Steven J., Rosen, Peter J., Nguyen, Tim, Gribbin, Thomas, Diez, Pedro M. Quintana, Borad, Mitesh
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin For Patients With Relapsed/Refractory Multiple Myeloma: Results From a Phase 1/2 Trial
Berenson, James R., Hilger, James D., Klein, Leonard, Bessudo, Alberto, Rosen, Peter J., Eshaghian, Shahrooz, Nassir, Youram, Swift, Regina A., Vescio, Robert
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article